Table 1.
Socio-demographic characteristics of the study participants at JUMC, April 24 to July 24/2017, Ethiopia (N = 300).
Table 2.
Clinical characteristics of study participants at JUMC, April 24 to July 24/2017, Ethiopia.
Table 3.
Patients’ medication information among patient admitted to the surgery ward of JUMC, 24 April to 24 July 2017, Ethiopia.
Fig 1.
Prevalence of ABURPs among patients admitted at surgery ward of JUMC April 24 to July 24/2017 Ethiopia.
N.B: ABURPs- antimicrobial use related problems.
Table 4.
Types and causes of antibiotic use-related problems identified at the surgical ward of JUMC from 24 April to 24 July 2017, Ethiopia.
Fig 2.
Top 10 antibiotics involved in ABURP during study period, JUMC, 2017 Ethiopia.
N.B; other = amoxicillin, cephalexin, tinidazole, clindamycin, vancomycin, norfloxacin, CAF = chloramphenicol, c. penicillin = crystalline penicillin, + (Pluss) = concurrent use.
Table 5.
ABURPs extra cost (direct cost for antibiotics) within 3 months (24 April to 24 July)2017 from the patient and government perspective, JUMC, Ethiopia.
Table 6.
Multivariate logistic regression analysis for the determinants of antibiotic use-related problems among patients admitted to the surgical ward of JUMC, from 24 April to 24 July 2017, Ethiopia.